Berkshire Biomedical Today Launched Its First Public Investment Campaign to Support the Advancement of Its Revolutionary COPA™ Technology DALLAS, Feb. 24, 2025 /PRNewswire/ — Berkshire Biomedical Corporation (“Berkshire” or the “Company”), focused on developing its proprietary drug…